Author:
Fortman Dylan,Issa Rochell,Stanbery Laura,Albrethsen Mary,Nemunaitis John,Kasunic Timothy
Subject
Obstetrics and Gynecology,Oncology
Reference10 articles.
1. Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluation;Astolfi;Oncol. Rep.,2013
2. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review;Boussios;Crit. Rev. Oncol./Hematol.,2016
3. Estimated cost of anticancer therapy directed by comprehensive genomic profiling in a single-center study;Chawla;JCO Precis. Oncol.,2018
4. D’Souza, et al., 2019. Neratinib in patients with HER2-mutant, metastatic cervical cancer: findings from the phase 2 SUMMIT ‘basket’ trial. 2019 SGO Annual Meeting. March 16–19, 2019; Honolulu, HI. Abstract 18.
5. Current and future therapies for targeting HER2 mutations in gastrointestinal cancer;El Dika;Expert Rev. Anticancer Ther.,2018
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献